A study published in Science of the Total Environment sheds light on the persistent chemical contaminants left behind at ...

A: It’s great that you’re asking early — not on the night of the first freeze. After watering each plant, set each one in a ...

Most will travel to the Southern U.S., while some long-distance migratory birds leave the United States entirely to winter in ...

Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in ...

Regulatory T cells help your immune system distinguish between ‘self’ and ‘nonself’ – and can open doors to better treatments for cancer, autoimmune disease and transplant rejection.

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...

The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ immunotherapy, Libtayo, as an add-on treatment for skin cancer patients at high risk of their disease returning ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Imagine how much you could ...

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring ...

This 3-part series looks at the current evidence for the treatment of SUDs. Part 2 reviews the use of GLP-1 receptor agonists and alcohol use disorder.

Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.

IMPACT-HTN, a novel initiative to modernize hypertension care, has been launched by Idorsia at Stanford Hypertension Center and Duke Heart Center.